Nature Publishing Group, publisher of Nature, and other science journals and reference works
Nature
my account e-alerts subscribe register
   
Sunday 05 July 2009
Journal Home
Current Issue
AOP
Archive
Download PDF
References
Export citation
Export references
Send to a friend
More articles like this

Letters to Nature
Nature 358, 417 - 421 (30 July 1992); doi:10.1038/358417a0

Raf-1 activates MAP kinase-kinase

John M. Kyriakis, Harald App*, Xian-feng Zhang, Papia Banerjee, David L. Brautigan, Ulf R. Rapp* & Joseph Avruch

Diabetes Unit, Medical Services, Massachusetts General Hospital, 149 13th Street, Charlestown, Massachusetts 02129, and Department of Medicine, Harvard Medical School, Boston,Massachusetts 02114, USA
* Laboratory of Viral Carcinogenesis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702, USA
Division of Biology and Medicine, Brown University, Providence, Rhode Island 02912, USA

THE normal cellular homologue of the acutely transforming oncogene v-ra/is c-raf-l, which encodes a serine/threonine protein kinase that is activated by many extracellular stimuli1. The physiological substrates of the protein c-Raf-1 are unknown. The mitogen-activated protein (MAP) kinases ErkI and 2 are also activated by mitogens through phosphorylation of Erk tyrosine and threonine residues catalysed by a protein kinase of relative molecular mass 50,000, MAP kinase-kinase (MAPK-K)2–7. Here we report that MAPK-K as well as Erkl and 2 are constitutively active in v-raf-transformed cells. MAPK-K partially purified from v-raf-transformed cells or from mitogen-treated cells3 can be deactivated by phosphatase 2A. c-Raf-1 purified after mitogen stimulation can reactivate the phosphatase 2A-inactivated MAPK-K over 30-fold in vitro. c-Raf-1 reactivation of MAPK-K coincides with the selective phosphorylation at serine/threonine residues of a polypeptide with M r 50,000 which coelutes precisely on cation-exchange chromatography with the MAPK-K activatable by c-Raf-1. These results indicate that c-Raf-1 is an immediate upstream activator of MAPK-K in vivo. To our knowledge, MAPK-K is the first physiological substrate of the c-raf-l protooncogene product to be identified.

------------------

References
1. Rapp, U. R. Oncogene 6, 495−500 (1991). | PubMed | ChemPort |
2. Ahn, N. G., Weiel, J. E., Chan, C. P. & Krebs, E. G. J. biol. Chem. 265, 11487−11494 (1990). | PubMed | ChemPort |
3. Kyriakis, J. M., Brautigan, D. L., Ingelbritsen, T. S. & Avruch, J. J. biol. Chem. 266, 10043−10046 (1991). | PubMed | ChemPort |
4. Anderson, N. G., Maller, J. L., Tonks, N. K. & Sturgill, T. W. Nature 343, 651−653 (1990). | Article | PubMed | ISI | ChemPort |
5. Ahn, N. G., et al. J. biol. Chem. 266, 4220−4227 (1991). | PubMed | ISI | ChemPort |
6. Gomez, N. & Cohen, P. Nature 353, 170−173 (1991). | Article | PubMed | ISI | ChemPort |
7. Allemain, G. L., Her, J.-H., Wu, J., Sturgill, T. W. & Weber, M. J. Molec. cell. Biol. 12, 2222−2229 (1992). | PubMed |
8. Rapp, U. R., Reynolds, F. H. & Stephenson, J. R. J. Virol. 45, 914−924 (1983). | PubMed | ISI | ChemPort |
9. Matsuda, S. et al. EMBO J. 11, 973−982 (1992). | PubMed | ISI | ChemPort |
10. Pulverer, B. J., et al. Nature 353, 670−674 (1991). | Article | PubMed | ISI | ChemPort |
11. Sturgill, T. W., Ray, L. B., Erikson, E. & Maller, J. L. Nature 334, 715−718 (1988). | Article | PubMed | ISI | ChemPort |
12. Dent, P. et al. Nature 348, 302−308 (1990). | Article | PubMed | ISI | ChemPort |
13. Anderson, N. G. et al. Biochem. J. 277, 573−576 (1991). | PubMed | ChemPort |
14. Lee, R.-M., Cobb, M. H. & Blackshear, P. J. J. biol. Chem. 267, 1088−1092 (1992). | PubMed | ISI | ChemPort |
15. Downward, J. et al. Nature 346, 719−723 (1990). | Article | PubMed | ISI | ChemPort |
16. Burgering, B. M. et al. EMBO J. 10, 1103−1109 (1991). | PubMed | ISI | ChemPort |
17. Satoh, T., Nakafuku, M., Miyajima, A. & Kaziro, Y. Proc natn. Acad. Sci. U.S.A. 88, 3314−3318 (1991). | ChemPort |
18. Leevers, S. J. & Marshall, C. J. EMBO J. 11, 569−574 (1992). | PubMed | ISI | ChemPort |
19. Bruder, J. T., Heidecker, G. & Rapp, U. R. Genes Dev. 6, 545−556 (1992). | PubMed | ISI | ChemPort |
20. Troppmair, J. et al. Oncogene (in the press).
21. Grove, J. R., Price, D. J., Goodman, H. M. & Avruch, J. Science 238, 530−533 (1987). | PubMed | ChemPort |
22. Hsi, E. D. et al. J. Biol. Chem. 264, 10836−10842 (1989). | PubMed | ISI | ChemPort |
23. Kyriakis, J. M. & Avruch, J. J. biol. Chem. 265, 17355−17363 (1990). | PubMed | ISI | ChemPort |
24. Takeda, M. et al. J. biol. Chem. 258, 10455−10463 (1988).
25. Jones, S. W., Erikson, R. L., Ingebritsen, V. M. & Ingebritsen, T. S. J. biol. Chem. 264, 7747−7753 (1989). | PubMed | ChemPort |
26. Kyriakis, J. M. & Avruch, J. Biochem. Biophys. Acta 1054, 73−82 (1990). | PubMed | ChemPort |



© 1992 Nature Publishing Group
Privacy Policy